Reducing amphotericin B reactions. 3. Use of a preparation with increased phosphate buffer.
D000328:Adult; D000666:Amphotericin B / Q000009:adverse effects*; D001759:Blastomycosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003047:Coccidioidomycosis / Q000188:drug therapy*; D003453:Cryptococcosis / Q000188:drug therapy*; D005260:Female; D006660:Histoplasmosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013174:Sporotrichosis / Q000188:drug therapy*
D000666:Amphotericin B